医学
氧化应激
胰岛素抵抗
炎症
代谢综合征
一氧化氮
伊诺斯
内皮功能障碍
糖尿病
脂肪组织
病理生理学
疾病
内科学
脂肪因子
生物信息学
一氧化氮合酶
内分泌学
生物
作者
Aida A. Hussein,Noha A. Ahmed,Hader I. Sakr,Tarek Atia,Osama M. Ahmed
标识
DOI:10.1080/13813455.2023.2283685
摘要
AbstractOmentin (intelectin) was first detected in the visceral omental adipose tissue. It has mainly two isoforms, omentin-1 and -2, with isoform-1 being the main form in human blood. It possesses insulin-sensitizing, anti-inflammatory, anti-atherogenic, cardio-protective, and oxidative stress-decreasing effects. Omentin’s cardiovascular protective actions are caused by the improved endothelial cell survival and function, increased endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) bioavailability, enhanced vascular smooth muscle cells (VSMCs) relaxation with reduced proliferation, decreased inflammation, and suppressed oxidative stress. Omentin may also have a potential role in different cancer types and rheumatic diseases. Thus, omentin is an excellent therapeutic target in many diseases, including diabetes mellitus (DM), metabolic syndrome (MetS), cardiovascular diseases (CVDs), inflammatory diseases, and cancer. This review demonstrates the physiological functions of omentin in ameliorating insulin resistance (IR), vascular function, and inflammation and its possible share in managing obesity-linked diseases, such as metabolic disorders, DM, and cardiovascular conditions.Keywords: Adipokinesomentindiabetes mellituscardiovascular diseasesmetabolic disordersinflammationrheumatic diseasescancer Consent to publicationAll authors accept to transmit the authors’ right to the publishing journal upon acceptance.Authors’ contributionAll authors read and approved the manuscript.Disclosure statementThe authors declare that they have no conflict of interest.Availability of dataThe authors confirm that the data supporting the findings of this study are available within the article.
科研通智能强力驱动
Strongly Powered by AbleSci AI